Offer - Urjas Oil for just ₹ 1 X
Xalipat 50 Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Colorectal Cancer. Other than this, Xalipat 50 Injection has some other therapeutic uses, which have been discussed ahead.
The right dosage of Xalipat 50 Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Xalipat 50 Injection as well, which are listed below. Usually, these side effects of Xalipat 50 Injection go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Xalipat 50 Injection has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Xalipat 50 Injection related warnings talks about Xalipat 50 Injection's effects on the liver, heart and kidney.
Xalipat 50 Injection is contraindicated in people with pre-existing medical conditions like Arrhythmia as it can result in adverse effects. The section on Xalipat 50 Injection contraindications lists all such conditions.
Drug interactions for Xalipat 50 Injection have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Xalipat 50 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Xalipat 50 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Xalipat 50 Injection safe for pregnant women?
Xalipat should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Xalipat 50 Injection safe during breastfeeding?
Xalipat should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Xalipat 50 Injection on the Kidneys?
Xalipat may have mild side effects on the kidneys.
What is the effect of Xalipat 50 Injection on the Liver?
Xalipat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Xalipat 50 Injection on the Heart?
Xalipat can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Xalipat 50 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Xalipat 50 Injection unless your doctor advises you to do so -
Is this Xalipat 50 Injection habit forming or addictive?
No, there is no any evidence that Xalipat 50 Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Xalipat 50 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Xalipat 50 Injection only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Xalipat 50 Injection for mental disorders.
Interaction between Food and Xalipat 50 Injection
Taking Xalipat 50 Injection with food does not harm your health.
Interaction between Alcohol and Xalipat 50 Injection
Taking alcohol with Xalipat 50 Injection can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 954-956
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Eloxatin (oxaliplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Oxaliplan™ (oxaliplatin)